<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="manner" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">4. Discussion</segment>
<segment id="2" parent="1003" relname="attribution">Here , we show</segment>
<segment id="3" parent="1003" relname="span">that the primary infection of mice with IDV does not result in disease ,</segment>
<segment id="4" parent="1004" relname="span">as mice demonstrated none of the clinical symptoms</segment>
<segment id="5" parent="4" relname="elaboration">associated with the typical progression of IAV infection .</segment>
<segment id="6" parent="1006" relname="span">In addition , infection with IDV did not inhibit bacterial clearance after secondary challenge with S. aureus .</segment>
<segment id="7" parent="1007" relname="span">In fact , we found decreased morbidity and increased survival of IDV-infected mice in response to bacterial challenge</segment>
<segment id="8" parent="1008" relname="span">when compared to mice</segment>
<segment id="9" parent="8" relname="elaboration">that were challenged with bacteria alone .</segment>
<segment id="10" parent="1011" relname="attribution">Our findings demonstrate</segment>
<segment id="11" parent="1011" relname="joint">that mice are not susceptible to secondary bacterial infection post-IDV infection</segment>
<segment id="12" parent="1013" relname="attribution">and suggest</segment>
<segment id="13" parent="1013" relname="span">that IDV-mediated anti-viral host responses may help to clear the bacteria</segment>
<segment id="14" parent="13" relname="means">by priming a protective inflammatory response .</segment>
<segment id="15" parent="1015" relname="span">We will discuss these results in the context of IDV pathogenesis and the regulation of secondary bacterial infections</segment>
<segment id="16" parent="15" relname="elaboration">as they compare with our previous findings with IAV .</segment>
<segment id="17" parent="1018" relname="attribution">Our results demonstrate</segment>
<segment id="18" parent="1018" relname="span">that infection of mice with OK11 IDV does not cause mice to exhibit the clinical symptoms</segment>
<segment id="19" parent="18" relname="elaboration">that are normally associated with influenza disease progression .</segment>
<segment id="20" parent="21" relname="concession">Although we did observe the recruitment of lymphocytes and neutrophils to the lung during OK11 infection ,</segment>
<segment id="21" parent="1020" relname="span">we did not observe a decrease in body weight .</segment>
<segment id="22" parent="1022" relname="span">Usually , the recruitment of inflammatory cells results in increased signs of morbidity ,</segment>
<segment id="23" parent="1023" relname="span">as we have previously found with other IAV subtypes</segment>
<segment id="24" parent="23" relname="elaboration">that induce cellular recruitment .</segment>
<segment id="25" parent="1026" relname="span">Additionally , we did not see a decrease in macrophage levels in mice</segment>
<segment id="26" parent="25" relname="elaboration">that were infected with IDV ,</segment>
<segment id="27" parent="1027" relname="span">which is a common observation</segment>
<segment id="28" parent="27" relname="elaboration">following IAV infection in C57BL/6 mice .</segment>
<segment id="29" parent="1031" relname="attribution">These results indicate</segment>
<segment id="30" parent="1031" relname="span">that the inflammatory environment during IDV infection is subdued</segment>
<segment id="31" parent="30" relname="circumstance">when compared to other influenza virus infections .</segment>
<segment id="32" parent="1033" relname="span">Specifically , the high level of macrophages</segment>
<segment id="33" parent="1034" relname="span">that are still present at day 7 post-OK11 may aid</segment>
<segment id="34" parent="1035" relname="span">in preventing the clinical symptoms</segment>
<segment id="35" parent="34" relname="elaboration">that were observed after IAV infection .</segment>
<segment id="36" parent="1036" relname="span">Similar to other groups ,</segment>
<segment id="37" parent="1037" relname="span">we have previously investigated infection by the PR8 strain of IAV in mice</segment>
<segment id="38" parent="1039" relname="attribution">and demonstrated</segment>
<segment id="39" parent="1039" relname="span">that primary PR8 infection can increase morbidity and mortality of secondary bacterial infection</segment>
<segment id="40" parent="39" relname="elaboration">as compared to infection of mice with bacteria alone .</segment>
<segment id="41" parent="1044" relname="attribution">In this study , we demonstrate</segment>
<segment id="42" parent="1045" relname="span">that there is a protective effect of primary IDV infection during secondary S. aureus infection</segment>
<segment id="43" parent="42" relname="elaboration">that is not observed in mice</segment>
<segment id="44" parent="1045" relname="elaboration">infected with bacteria alone .</segment>
<segment id="45" parent="1047" relname="span">Specifically , OK11-infected mice</segment>
<segment id="46" parent="1048" relname="span">challenged with S. aureus were less susceptible to clinical signs of disease</segment>
<segment id="47" parent="46" relname="elaboration">( weight loss )</segment>
<segment id="48" parent="1049" relname="span">and mortality</segment>
<segment id="49" parent="1050" relname="span">when compared to mice</segment>
<segment id="50" parent="49" relname="elaboration">that received S. aureus alone .</segment>
<segment id="51" parent="1052" relname="attribution">This suggests</segment>
<segment id="52" parent="1052" relname="span">that IDV induces host anti-viral mechanisms</segment>
<segment id="53" parent="52" relname="elaboration">that are protective against secondary bacterial infection .</segment>
<segment id="54" parent="55" relname="attribution">Interestingly , we found</segment>
<segment id="55" parent="1054" relname="span">that , in addition to OK11 infection alone , secondary bacterial infection of OK11-infected mice also does not decrease the level of macrophages .</segment>
<segment id="56" parent="1057" relname="attribution">This suggests</segment>
<segment id="57" parent="58" relname="attribution">that macrophages may be involved</segment>
<segment id="58" parent="1057" relname="span">in mediating protection from secondary bacterial challenge .</segment>
<segment id="59" parent="1060" relname="attribution">Our previous work with PR8-infected C57BL/6 mice showed</segment>
<segment id="60" parent="1060" relname="joint">that protective alveolar macrophages are depleted over the course of IAV infection</segment>
<segment id="61" parent="1061" relname="span">and replaced by damaging inflammatory monocytes/neutrophils</segment>
<segment id="62" parent="61" relname="elaboration">that contribute to secondary bacterial susceptibility .</segment>
<segment id="63" parent="1064" relname="attribution">However , Califano , Furuya , and Metzger ( 2013 ) demonstrated</segment>
<segment id="64" parent="1065" relname="span">that macrophage dysfunction , rather than depletion , in C57BL/6 mice</segment>
<segment id="65" parent="1066" relname="span">that were infected with IAV is a factor</segment>
<segment id="66" parent="65" relname="elaboration">that contributes to increased susceptibility to secondary bacterial infection ,</segment>
<segment id="67" parent="1064" relname="joint">and our previous PR8-infected mouse data supports this .</segment>
<segment id="68" parent="1001" relname="joint">It will be important to determine the macrophage phenotypic properties over the course of IDV infection ,</segment>
<segment id="69" parent="1068" relname="span">and compare them with IAV responses</segment>
<segment id="70" parent="69" relname="purpose">to define how macrophages contribute to this protection from secondary bacterial infection .</segment>
<group id="1000" type="span" />
<group id="1001" type="multinuc" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="joint"/>
<group id="1003" type="span" parent="1002" relname="span"/>
<group id="1004" type="span" parent="3" relname="circumstance"/>
<group id="1006" type="span" parent="1001" relname="joint"/>
<group id="1007" type="span" parent="6" relname="elaboration"/>
<group id="1008" type="span" parent="7" relname="circumstance"/>
<group id="1010" type="span" parent="1001" relname="joint"/>
<group id="1011" type="multinuc" parent="1010" relname="span"/>
<group id="1012" type="span" parent="1011" relname="joint"/>
<group id="1013" type="span" parent="1012" relname="span"/>
<group id="1015" type="span" parent="1001" relname="joint"/>
<group id="1017" type="span" parent="1001" relname="joint"/>
<group id="1018" type="span" parent="1017" relname="span"/>
<group id="1020" type="span" parent="1001" relname="joint"/>
<group id="1022" type="span" parent="1001" relname="joint"/>
<group id="1023" type="span" parent="22" relname="manner"/>
<group id="1025" type="span" parent="1001" relname="joint"/>
<group id="1026" type="span" parent="1025" relname="span"/>
<group id="1027" type="span" parent="1026" relname="elaboration"/>
<group id="1029" type="span" parent="1001" relname="joint"/>
<group id="1030" type="span" parent="1029" relname="span"/>
<group id="1031" type="span" parent="1030" relname="span"/>
<group id="1032" type="span" parent="1030" relname="elaboration"/>
<group id="1033" type="span" parent="1032" relname="span"/>
<group id="1034" type="span" parent="32" relname="elaboration"/>
<group id="1035" type="span" parent="33" relname="elaboration"/>
<group id="1036" type="span" parent="1033" relname="elaboration"/>
<group id="1037" type="span" parent="36" relname="elaboration"/>
<group id="1038" type="span" parent="37" relname="elaboration"/>
<group id="1039" type="span" parent="1038" relname="span"/>
<group id="1041" type="span" parent="1001" relname="joint"/>
<group id="1042" type="span" parent="1041" relname="span"/>
<group id="1043" type="span" parent="1042" relname="span"/>
<group id="1044" type="span" parent="1043" relname="span"/>
<group id="1045" type="span" parent="1044" relname="span"/>
<group id="1046" type="multinuc" parent="1043" relname="elaboration"/>
<group id="1047" type="span" parent="1046" relname="joint"/>
<group id="1048" type="span" parent="45" relname="elaboration"/>
<group id="1049" type="span" parent="1046" relname="joint"/>
<group id="1050" type="span" parent="48" relname="circumstance"/>
<group id="1051" type="span" parent="1042" relname="elaboration"/>
<group id="1052" type="span" parent="1051" relname="span"/>
<group id="1054" type="span" parent="1001" relname="joint"/>
<group id="1056" type="span" parent="1001" relname="joint"/>
<group id="1057" type="span" parent="1056" relname="span"/>
<group id="1059" type="span" parent="1001" relname="joint"/>
<group id="1060" type="multinuc" parent="1059" relname="span"/>
<group id="1061" type="span" parent="1060" relname="joint"/>
<group id="1063" type="span" parent="1001" relname="joint"/>
<group id="1064" type="multinuc" parent="1063" relname="span"/>
<group id="1065" type="span" parent="1064" relname="joint"/>
<group id="1066" type="span" parent="64" relname="elaboration"/>
<group id="1068" type="span" parent="1001" relname="joint"/>
	</body>
</rst>
